Daratumumab plus Cyclophosphamide, Bortezomib and Dexamethasone (Dara-CyBorD) in Previously Untreated and Relapsed Subjects with Multiple Myeloma - Regional Cancer Care Associates LLC

Clinical Trials

Daratumumab plus Cyclophosphamide, Bortezomib and Dexamethasone (Dara-CyBorD) in Previously Untreated and Relapsed Subjects with Multiple Myeloma

Type of Cancer
Multiple Myeloma
Locations
Bethesda
Sponsor
Protocol Number
54767414MMY2012
Cancer Diagnosis
To Learn More Call
201-510-0910